Figure 1.

Fetal testosterone exposure moderates effects of oxytocin on inclusion decisions. Low-threat targets [(A) examples in bottom left panel] are preferred less and high-threat targets [(B) examples in bottom right panel] are preferred more by individuals with high fetal testosterone vs. estradiol exposure when given oxytocin rather than placebo. Fetal testosterone vs. estradiol prenatal priming ratio was included as a continuous variable in our model. For visualization purposes, we plotted the interaction with this continuous variable centered once at +1 SD (dotted lines) and once at −1 SD (solid lines).